SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-18-028587
Filing Date
2018-04-30
Accepted
2018-04-30 16:30:33
Documents
4
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a18-12367_110ka.htm 10-K/A 1195618
2 EX-31.1 a18-12367_1ex31d1.htm EX-31.1 5218
3 EX-31.2 a18-12367_1ex31d2.htm EX-31.2 5050
4 GRAPHIC g123671bki001.jpg GRAPHIC 10695
  Complete submission text file 0001104659-18-028587.txt   1221776
Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37691 | Film No.: 18790264
SIC: 2834 Pharmaceutical Preparations